Machine learning for synthetic data generation: a review

Y Lu, M Shen, H Wang, X Wang, C van Rechem… - arXiv preprint arXiv …, 2023 - arxiv.org
Machine learning heavily relies on data, but real-world applications often encounter various
data-related issues. These include data of poor quality, insufficient data points leading to …

Prediction of Clinical Trials Outcomes Based on Target Choice and Clinical Trial Design with Multi‐Modal Artificial Intelligence

A Aliper, R Kudrin, D Polykovskiy… - Clinical …, 2023 - Wiley Online Library
Drug discovery and development is a notoriously risky process with high failure rates at
every stage, including disease modeling, target discovery, hit discovery, lead optimization …

ECOD: Unsupervised Outlier Detection Using Empirical Cumulative Distribution Functions

Z Li, Y Zhao, X Hu, N Botta, C Ionescu… - IEEE Transactions on …, 2022 - ieeexplore.ieee.org
Outlier detection refers to the identification of data points that deviate from a general data
distribution. Existing unsupervised approaches often suffer from high computational cost …

Molgensurvey: A systematic survey in machine learning models for molecule design

Y Du, T Fu, J Sun, S Liu - arXiv preprint arXiv:2203.14500, 2022 - arxiv.org
Molecule design is a fundamental problem in molecular science and has critical applications
in a variety of areas, such as drug discovery, material science, etc. However, due to the large …

A review on the recent applications of deep learning in predictive drug toxicological studies

K Sinha, N Ghosh, PC Sil - Chemical Research in Toxicology, 2023 - ACS Publications
Drug toxicity prediction is an important step in ensuring patient safety during drug design
studies. While traditional preclinical studies have historically relied on animal models to …

Trialbench: Multi-modal artificial intelligence-ready clinical trial datasets

J Chen, Y Hu, Y Wang, Y Lu, X Cao, M Lin, H Xu… - arXiv preprint arXiv …, 2024 - arxiv.org
Clinical trials are pivotal for developing new medical treatments, yet they typically pose
some risks such as patient mortality, adverse events, and enrollment failure that waste …

TWIN-GPT: Digital Twins for Clinical Trials via Large Language Model

Y Wang, T Fu, Y Xu, Z Ma, H Xu, B Du, Y Lu… - ACM Transactions on …, 2024 - dl.acm.org
Clinical trials are indispensable for medical research and the development of new
treatments. However, clinical trials often involve thousands of participants and can span …

Uncertainty quantification on clinical trial outcome prediction

T Chen, N Hao, Y Lu, C Van Rechem - arXiv preprint arXiv:2401.03482, 2024 - arxiv.org
The importance of uncertainty quantification is increasingly recognized in the diverse field of
machine learning. Accurately assessing model prediction uncertainty can help provide …

A systematic survey in geometric deep learning for structure-based drug design

Z Zhang, J Yan, Q Liu, E Chen, M Zitnik - arXiv preprint arXiv:2306.11768, 2023 - arxiv.org
Structure-based drug design (SBDD) utilizes the three-dimensional geometry of proteins to
identify potential drug candidates. Traditional methods, grounded in physicochemical …

Uncertainty quantification and interpretability for clinical trial approval prediction

Y Lu, T Chen, N Hao, C Van Rechem, J Chen… - Health Data …, 2024 - spj.science.org
Background: Clinical trial is a crucial step in the development of a new therapy (eg,
medication) and is remarkably expensive and time-consuming. Forecasting the approval of …